Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 24.93
+0.38 (1.55%)
At close: Aug 4, 2026
SHE:301258 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 412.51 | 432.73 | 429.47 | 489.29 | 568.21 | 521.7 |
Revenue Growth | -7.56% | 0.76% | -12.23% | -13.89% | 8.92% | 9.40% |
Gross Profit Gross Profit Growth | 71.59 | 74.64 | 81.43 | 188.07 | 253.31 | 207.45 |
Operating Income Operating Income Growth | -13.39 | -7.69 | -9.16 | 92.89 | 158.77 | 137.04 |
Net Income Net Income Growth | 37.59 | 64.29 | 16.41 | 112.18 | 177.31 | 120.2 |
Earnings Per Share EPS Growth | 0.42 | 0.71 | 0.18 | 1.22 | 2.06 | 1.75 |
EPS Growth | 9.85% | 294.44% | -85.25% | -40.78% | 17.71% | -14.63% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Business Pharmaceutical Business Growth | 406.96 | 427.18 | 426.01 | 483.1 | 548.95 | 511.66 |
Unallocated Other Business Unallocated Other Business Growth | - | 5.55 | 3.46 | 6.19 | 19.26 | 10.03 |
Total Total Growth | 412.51 | 432.73 | 429.47 | 489.29 | 568.21 | 521.7 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,164 | 1,261 | 1,348 | 1,419 | 1,421 | 353.67 |
Total Debt Total Debt Growth | 0.84 | 1.01 | 1.67 | 2.25 | 2.82 | 18.58 |
Net Cash (Debt) Net Cash Growth | 1,164 | 1,260 | 1,346 | 1,417 | 1,418 | 335.09 |
Net Cash Growth | -12.43% | -6.42% | -5.00% | -0.06% | 323.12% | 53.65% |
Net Cash Per Share Net Cash Per Share Growth | 12.92 | 13.91 | 14.77 | 15.41 | 16.47 | 4.88 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 36.75 | 66.6 | 47.07 | 94.77 | 151.19 | 199.73 |
Capital Expenditures CapEx Growth | -166.14 | -146.5 | -105.31 | -41.62 | -50.11 | -80.75 |
Free Cash Flow Free Cash Flow Growth | -129.39 | -79.9 | -58.25 | 53.15 | 101.08 | 118.98 |
Free Cash Flow Growth | - | - | - | -47.42% | -15.05% | 17.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 17.36% | 17.25% | 18.96% | 38.44% | 44.58% | 39.77% |
Operating Margin | -3.25% | -1.78% | -2.13% | 18.98% | 27.94% | 26.27% |
Pretax Margin | 10.58% | 17.30% | 4.24% | 26.27% | 35.63% | 26.54% |
Profit Margin | 9.11% | 14.86% | 3.82% | 22.93% | 31.20% | 23.04% |
FCF Margin | -31.37% | -18.46% | -13.56% | 10.86% | 17.79% | 22.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.220 | 0.220 | 0.091 | 0.600 | 0.580 | 0.400 |
Dividend Per Share Growth | 141.76% | 141.76% | -84.83% | 3.45% | 45.00% | -42.86% |
Dividend Yield | 0.90% | 0.68% | 0.39% | 1.92% | 1.55% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 59.71 | 45.33 | 131.23 | 26.38 | 20.29 | - |
P/FCF Ratio | - | - | - | 55.68 | 35.60 | - |
PS Ratio | 5.35 | 6.74 | 5.01 | 6.05 | 6.33 | - |